1990
DOI: 10.1590/s0036-46651990000400006
|View full text |Cite
|
Sign up to set email alerts
|

Screening the mutagenic activities of coomonly used antiparasite drugs by the Simultest, a simplified Salmonella/microsome plate incorporation assay

Abstract: The mutagenic activities of 16 anti-parasite drugs were screened by the Simultest in both qualitative (spot test) and quantitative (plate incorporation) assays with a Salmonella typhimurium pool composed by the indicator strains TA97, TA98, TA100 and TA102. Four anti Chagas' disease drugs (nifurtimox, benznidazole, CL 64,855, and MK 436) and two anti-amebae drugs (metronidazole and tinidazole) gave positive results in qualitative tests and incorporation of rat liver microsomes did not alter the results. Compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
2

Year Published

1994
1994
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 14 publications
0
8
0
2
Order By: Relevance
“…Several free radical species similar to those produced by NFX were thought to be involved [4, 14]. It is mutagenic for Salmonella typhimurium [19, 20, 22, 33–36] as well as the urine and blood of treated animals [25]. Its clastogenic ability is controversial since both positive [27, 28, 37–43] and negative [44] findings are reported.…”
Section: Introductionmentioning
confidence: 99%
“…Several free radical species similar to those produced by NFX were thought to be involved [4, 14]. It is mutagenic for Salmonella typhimurium [19, 20, 22, 33–36] as well as the urine and blood of treated animals [25]. Its clastogenic ability is controversial since both positive [27, 28, 37–43] and negative [44] findings are reported.…”
Section: Introductionmentioning
confidence: 99%
“…possible human carcinogen, as it has shown mutagenic activity in vitro including positive Ames test, although studies in vivo have failed to demonstrate a potential for genotoxicity 3,4 . This active substance has been used for the treatment of bacterial infections for above 45 years, but still metronidazole is successfully used for the treatment of vaginosis, trichomoniasis, amoebiasis, and giardiasis, and still it is the criterion standard for therapy of anaerobic bacterial infections 5 , although during last decades many new derivatives of metronidazole were investigated with antibacterial, antifungal and also H. pylori urease inhibitory activity.…”
Section: Fig 1 Metronidazolementioning
confidence: 99%
“…Esto indica que el ensayo masivo en epimastigotes es una buena prueba de tamización con miras a encontrar compuestos activos en otros estadios del parásito.Todos los extractos y fracciones activos contra T. cruzi podrían ser candidatos para continuar los estudios, ya que la gran citotoxicidad podría deberse a sustancias diferentes a las que están actuando sobre los parásitos o a un efecto sinérgico entre las sustancias presentes en el extracto crudo, y podría disminuir con la separación en fracciones o con el aislamiento de moléculas (29). También, sería importante determinar la genotocixidad de los extractos activos como una aproximación a la identificación de las causas de los efectos colaterales, como ocurre con el benznidazol, cuyo potencial genotóxico se ha demostrado (30,31).…”
Section: Muy Activosunclassified